Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.5M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
479K
-
Shares change
-
+463K
-
Total reported value, excl. options
-
$5.18M
-
Value change
-
+$5.01M
-
Number of buys
-
15
-
Price
-
$10.81
Significant Holders of FibroBiologics, Inc. - Common Stock (FBLG) as of Q1 2024
16 filings reported holding FBLG - FibroBiologics, Inc. - Common Stock as of Q1 2024.
FibroBiologics, Inc. - Common Stock (FBLG) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 479K shares
of 37.5M outstanding shares and own 1.28% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (209K shares), HRT FINANCIAL LP (57.3K shares), MARSHALL WACE, LLP (52K shares), CITIGROUP INC (30.4K shares), ExodusPoint Capital Management, LP (25.6K shares), JPMORGAN CHASE & CO (22.6K shares), NewEdge Advisors, LLC (17.9K shares), Point72 (DIFC) Ltd (15.9K shares), Balyasny Asset Management L.P. (14.2K shares), and BlackRock Inc. (13.2K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.